Tag: tiragolumab

  • The Roche Crisis Could Lead to Opportunity

    The Roche Crisis Could Lead to Opportunity

    Biopharma stocks are getting butchered. All after Roche Holding announced disappointing results from an experimental cancer drug called tiragolumab.  In fact, in a Phase 3 trial, the drug, delivered in combination with cancer drug Tecentriq failed to slow disease progression in non-small cell lung cancer patients. That news sent Roche down about $3.72 on the…